Local tumor overexpression of IL-6 has been observed in colorectal, prostate, pancreatic, lung, cervical, and breast cancer as well as in renal and ovarian carcinomas, confirming the important role of this cytokine in tumor survival and progression [14]. This evidence concerns the gene IL6 and breast cancer.